首页> 外文期刊>Basic & clinical pharmacology & toxicology. >FV22 PILOT RESULTS OF IMPLEMENTATION OF SOP TO REQUEST FOLLOW UP INFORMATION: DRUG SAFETY DEPARTMENT OF PFIZER SPAIN EXPERIENCE AFTER STANDARDIZATION OF THE REQUESTS FOR FURTHER INFORMATION
【24h】

FV22 PILOT RESULTS OF IMPLEMENTATION OF SOP TO REQUEST FOLLOW UP INFORMATION: DRUG SAFETY DEPARTMENT OF PFIZER SPAIN EXPERIENCE AFTER STANDARDIZATION OF THE REQUESTS FOR FURTHER INFORMATION

机译:FV22实施SOP要求后续信息的试验结果:标准化要求更多信息后,喷粉器西班牙服役的药品安全部门

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: In order to improve the quality of notifications, Pfizer implemented a new Standard Operating Procedure (SOP) to standardize the collection of information for the reports, regarding the seriousness, expectedness and source of the cases. We have reviewed the number of follow ups (FU) in order to establish if there has been an increase on them.Methods: The Pfizer Spain drug safety database was analyzed, comparing the reports included in a first period from July 2003 to December 2004 (prior to the SOP implementation) and the reports included in a second period from January 2005 to June 2006 (after the previous mentioned implementation). The total number of FU received to complete the information of the initial cases was compared, and the available information of the reports after the implementation was examined.Results: A total of 4830 cases were notified: 2326 (1413 initials, 913 FU) on the first and 2506 (1432 initials, 1074 FU) on the second period. During the first period the reported initials, FU and the% of the total were respectively, regarding the source: health professionals (HP) 617, 158 (20.3%); health authorities (HA) 134, 12 (8.2%); clinical trials (CT) 662, 743 (52.9%); and the expedited cases 166, 94 (36.2%). On the second period the reported cases were HP: 662, 265 (28.9%); HA: 220, 13 (5.6%); CT: 550, 796 (59.1%); and expedited cases 158, 136(86.1%).Conclusions: An increase on the FU that complete the initial information of the cases is observed. This increase mainly is observed in HP and clinical trial cases, but not in the notifications received from health authorities, probably because the request is done to the health authorities, instead of directly to the HP. Regarding the expedited cases notified to regulatory, an important increase in the FU is observed, which proves that the SOP is more effective with these cases. Moreover, if we take in consideration that after the SOP implementation a high number of reported cases have the required information, we consider that thisSOP enhances the information (enough to perform a correct case causality evaluation), and this will improve the quality of the reports.
机译:目标:为了提高通知的质量,辉瑞实施了新的《标准操作程序》(SOP),以标准化报告的信息收集,涉及案件的严重性,预期性和来源。方法:我们分析了辉瑞西班牙药品安全数据库,比较了2003年7月至2004年12月第一阶段的报告(在SOP实施之前)和第二期报告(从2005年1月至2006年6月)(在上述实施之后)。比较完成案例所需信息的FU总数,并检查实施后报告的可用信息。结果:总共通知了4830例案例:2326例(1313首字母,913 FU)首先,第二个周期为2506(缩写为1432,缩写为1074 FU)。在第一阶段,报告的姓名首字母FU和总数的百分比分别为:卫生专业人员(HP)617、158(20.3%);卫生部门(HA)134,12(8.2%);临床试验(CT)662,743(52.9%);加急案件166,94起(36.2%)。在第二阶段,报告的病例为HP:662,265(28.9%);医管局:220,13(5.6%); CT:550,796(59.1%);结论:观察到完成病例初始信息的FU有所增加,而快速病例为158,136(86.1%)。这种增加主要在HP和临床试验案例中观察到,但未在从卫生当局收到的通知中观察到,可能是因为请求是向卫生当局而不是直接向HP提出的。对于通知监管部门的快速案例,观察到的FU有了重要增加,这证明SOP在这些案例中更为有效。此外,如果我们考虑到在实施SOP之后,大量报告的案例具有所需的信息,我们认为thisSOP增强了信息(足以执行正确的案例因果关系评估),这将提高报告的质量。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号